Post Exposure Prophylaxis study (treated after exposure to the virus)
et al., New Microbes and New Infections, doi:10.1016/j.nmni.2020.100813 (Peer Reviewed)
Hydroxych loroquine for prophylaxis and treatment of COVID-19 in health care workers
100% reduction in cases with HC
Q+zinc post-exposure prophylaxis. Brief report for healthcare workers in Bulgaria.
0 cases with treatment vs. 3 for control.
156 treatment patients and 48 control patients.
No serious adverse events. This paper reports on both PEP and early treatment, we have separated the two studies.
COVID-19 case, ↓95.6%, p=0.01
(adjusted for zero)
Please send us corrections, updates, or comments.